Browsing Over 400 Presentations

Sort By
First line for oncogene addicted lung cancer Educational session

The role of first-line combination therapy for oncogene addicted lung cancer

Lecture Time
15:30 - 15:50
Presenter
  • Takashi Seto (JP)
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Takashi Seto (JP)
Combined treatment stage III Educational session

Q&A

Lecture Time
15:50 - 16:00
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
First line for oncogene addicted lung cancer Educational session

Q&A

Lecture Time
15:50 - 16:00
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Early stage NSCLC: Where do we stand in 2018? Educational session

Pathology and biomarkers in resected NSCLC

Lecture Time
16:50 - 17:10
Presenter
  • Elisabeth Brambilla (FR)
Session Name
Early stage NSCLC: Where do we stand in 2018?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Elisabeth Brambilla (FR)
First line for non-oncogene addicted lung cancer Educational session

Immunotherapy in the first-line setting: What have we achieved?

Lecture Time
16:50 - 17:10
Presenter
  • Martin Reck (DE)
Session Name
First line for non-oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Martin Reck (DE)
Early stage NSCLC: Where do we stand in 2018? Educational session

Neoadjuvant immunotherapy in early-stage NSCLC

Lecture Time
17:10 - 17:30
Presenter
  • Patrick M. Forde (US)
Session Name
Early stage NSCLC: Where do we stand in 2018?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Patrick M. Forde (US)
First line for non-oncogene addicted lung cancer Educational session

First-line therapy in PS2 and elderly patients: Any new signals?

Lecture Time
17:10 - 17:30
Presenter
  • Elisabeth Quoix (FR)
Session Name
First line for non-oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Elisabeth Quoix (FR)
Early stage NSCLC: Where do we stand in 2018? Educational session

Stereotactic radiotherapy for early stage NSCLC

Lecture Time
17:30 - 17:50
Presenter
  • Shankar Siva (AU)
Session Name
Early stage NSCLC: Where do we stand in 2018?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Shankar Siva (AU)
First line for non-oncogene addicted lung cancer Educational session

First-line therapy: What might we expect for the future?

Lecture Time
17:30 - 17:50
Presenter
  • Giorgio Scagliotti (IT)
Session Name
First line for non-oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Giorgio Scagliotti (IT)
Early stage NSCLC: Where do we stand in 2018? Educational session

Q&A

Lecture Time
17:50 - 18:00
Session Name
Early stage NSCLC: Where do we stand in 2018?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
First line for non-oncogene addicted lung cancer Educational session

Q&A

Lecture Time
17:50 - 18:00
Session Name
First line for non-oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Early stage NSCLC: Where do we stand in 2018? Educational session

Guidelines for surgery in ground glass opacities

Lecture Time
16:30 - 16:50
Presenter
  • Kenji Suzuki (JP)
Session Name
Early stage NSCLC: Where do we stand in 2018?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Kenji Suzuki (JP)